2
Announcements
Trials
Browse
Landscape
Phase
Phase 3
1
Status
Unknown
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Thoracic
1
Conditions
Nasopharyngeal Carcinoma
12
Esophageal Neoplasms
10
Esophageal Squamous Cell Carcinoma
8
Uterine Cervical Neoplasms
3
Squamous Cell Carcinoma of Head and Neck
3
Carcinoma, Squamous Cell
3
Carcinoma, Non-Small-Cell Lung
3
Recurrence
2
Stomach Neoplasms
1
Small Cell Lung Carcinoma
1
Resectable Lung Non-Small Cell Carcinoma
1
Ovarian Neoplasms
1
Neoplasms
1
Lymphoma
1
Immunotherapy Esophagus Cancer
1
Hypopharyngeal Neoplasms
1
Hepatic Artery Infusion
1
Head and Neck Neoplasms
1
Central Nervous System Neoplasms
1
Advanced Solid Tumor
1
Advanced Non-squamous Non-Small-Cell Lung Cancer
1
Interventions
sintilimab
1
nedaplatin
1
Pemetrexed
1
Bevacizumab
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Advanced Non-squamous Non-Small-Cell Lung Cancer
×
nedaplatin
×
Clear all
NCT05648071
2022-12-13
SPBPDC
Qianfoshan Hospital
Phase 3
Unknown
60 enrolled